Discover
CVKD
Cadrenal Therapeutics, Inc.
0.91
1 x 1.74
1 x 1.37
bid
ask
-
0.02
2.10%
1 @ 06:14 PM
0.91 -0.00 (0.01%)
| Ytd | -86.58% | |
| 1y | -93.59% |
0.90
day range
0.97
0.91
52 week range
14.19
| Open | 0.97 | Prev Close | 0.93 | Low | 0.90 | High | 0.97 | Mkt Cap | 3.25M |
| Vol | 83.75K | Avg Vol | 458.83K | EPS | -4.91 | P/E | N/A | Forward P/E | -3.02 |
| Beta | 1.93 | Short Ratio | 1.17 | Inst. Own | 4.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-21 | 50-d Avg | 1.43 | 200-d Avg | 4.47 | 1yr Est | 35.67 |
| Income Statement | |||
| Operating Expenses | 3.34M | ||
| Research and Development Expense | 705.15K | ||
| Selling, General and Administrative Expense | 2.63M | ||
| Operating Income | -3.34M | ||
| Net Income | -3.32M | ||
| Net Income Common Stock | -3.32M | ||
| Net Income Common Stock (USD) | -3.32M | ||
| Consolidated Income | -3.32M | ||
| Earnings per Basic Share | -1.14 | ||
| Earnings per Basic Share (USD) | -1.14 | ||
| Earnings per Diluted Share | -1.14 | ||
| Earning Before Interest & Taxes (EBIT) | -3.32M | ||
| Earning Before Interest & Taxes (USD) | -3.32M | ||
| Weighted Average Shares | 2.91M | ||
| Weighted Average Shares Diluted | 2.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.39M | ||
| Cash and Equivalents (USD) | 2.39M | ||
| Current Assets | 5.58M | ||
| Property, Plant & Equipment Net | 2.68K | ||
| Total Assets | 5.59M | ||
| Current Liabilities | 1.50M | ||
| Total Liabilities | 1.50M | ||
| Accumulated Retained Earnings (Deficit) | -44.78M | ||
| Shareholders Equity | 4.09M | ||
| Shareholders Equity (USD) | 4.09M | ||
| Assets Non-Current | 4.84K | ||
| Trade and Non-Trade Payables | 871.91K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 504.00 | ||
| Net Cash Flow from Financing | 2.31M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 80.00K | ||
| Capital Expenditure | 1.44K | ||
| Issuance (Purchase) of Equity Shares | 2.31M | ||
| Net Cash Flow from Investing | 1.44K | ||
| Net Cash Flow from Operations | -2.23M | ||
| Share Based Compensation | 672.10K | ||